NASDAQ:SINT 延时15分钟

成交量

B. Sonny Bal: B. Sonny Bal is currently the Chairman at SINTX Technologies, Inc. He is also a Member of the American Academy of Orthopaedic Surgeons, the American Association of Hip & Knees Surgeons, the International Society For Technology In Arthroplasty, and The Association of Bone & Joint Surgeons. Previously, he worked as an Associate Professor at the University of Missouri. He holds a graduate degree from the University of Missouri, an MBA from Northwestern University and the Kellogg School of Management, and doctorate degrees from Cornell University and the Kyoto Institute of Technology.

David W. Truetzel: David W. Truetzel is the founder of Augury Capital Management LLC, which was founded in 2006. He held the title of General Partner at the firm. Mr. Truetzel currently holds several positions, including Chairman at Paranet Solutions LLC, Director at Bonfyre, Inc., Director at Enterprise Bank, Inc., Independent Director at SINTX Technologies, Inc., Director at Verifi, Inc., Director at Paranet LLC, Director at Elm Tree Funds Ii LLC, and Director at Scholarpath, Inc.Mr. Truetzel has held former positions as Chief Financial Officer & Director at US Spine, Inc., Managing Director at A.G. Edwards & Sons, Inc., Managing Director at Gryphon Investments II LLC, Chief Financial Officer at Kinexus Co., Chief Financial Officer at PaylinX Corp., Chief Financial Officer at First USA, Inc., Chief Financial Officer at Paymentech, Inc., and General Partner at Hela Capital Partners LLC. Mr. Truetzel's education history includes an undergraduate degree from St. Louis University and an MBA from The Wharton School of the University of Pennsylvania.

B. Sonny Bal: B. Sonny Bal is currently the Chairman at SINTX Technologies, Inc. He is also a Member of the American Academy of Orthopaedic Surgeons, the American Association of Hip & Knees Surgeons, the International Society For Technology In Arthroplasty, and The Association of Bone & Joint Surgeons. Previously, he worked as an Associate Professor at the University of Missouri. He holds a graduate degree from the University of Missouri, an MBA from Northwestern University and the Kellogg School of Management, and doctorate degrees from Cornell University and the Kyoto Institute of Technology.

Jeffrey S. White: Jeffrey S. White is the founder of Applied Spine Technologies, Inc. (founded in 2004) and Medtech Advisory Group LLC (founded in 2013). He held the title of Chief Executive Officer & Vice President-Marketing at Applied Spine Technologies, Inc. and Principal at Medtech Advisory Group LLC. Mr. White's current job(s) include being an Independent Director at SINTX Technologies, Inc. (since 2014), a Director at Isotron, Inc., a Member of the International Society For The Advancement of Spine Surgery, and a Member of Ao Spine International. Mr. White's former job(s) include being a Senior Director-Business Development & Marketing at United States Surgical Corp., a Director at Cytonics Corp., the President & Director of Liventa Bioscience, Inc. (from 2014 to 2015), the Global Director-Business Development at Synthes, Inc. (from 2010 to 2012), a Director at Residency Select LLC, the Vice President-Product Management Strategies at MiMedx Group, Inc., and the Vice President & General Manager-Surgery at Richard-Allan Medical Ltd.Mr. White's education history includes completing his undergraduate degree at Union College (New York).

Eric A. Stookey: Eric A. Stookey is an Independent Director at SINTX Technologies, Inc. and the Chief Operating Officer at Osteoremedies LLC. He was previously an Independent Director at Cartiva, Inc. and the President-Extremities & Biologics Division at Wright Medical Group, Inc. He holds an MBA from Christian Brothers University and an undergraduate degree from Kelley School of Business.

Mark I. Froimson: Mark I. Froimson is currently Chairman & Chief Executive Officer at Lazurite Holdings LLC since 2024. He is an Independent Director at Pacira Biosciences, Inc. since 2017. He serves as Director at The Arthritis Foundation. He is Principal at Riverside Health Advisors LLC since 2017. Formerly, Dr. Froimson was President & Chief Executive Officer at Euclid Hospital from 2012 to 2014. He was President & Chief Executive Officer at Cleveland Clinic Hospital. He was Independent Director at SINTX Technologies, Inc. from 2019 to 2025. He served as Chief Clinical Officer & Executive Vice President at Trinity Health Corp. from 2014 to 2017. He was President of the American Association of Hip & Knees Surgeons from 2017 to 2018. He was Trustee at Cleveland Clinic Orthopedic & Rheumatologic Institute. Education includes an undergraduate degree from Princeton University in 1981, an MBA from Weatherhead School of Management, and a doctorate from Tulane University School of Medicine in 1985.

SINTX Technologies, Inc.